Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Journal of Addictive Diseases
|
September 26, 2002
Concurrent cocaine withdrawal alters alcohol withdrawal symptoms
Kyle M Kampman, Helen Pettinati, Joseph Volpicelli, et al.
Journal of Substance Abuse Treatment
|
March 2, 2012
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Charles A Dackis, Kyle M Kampman, Kevin G Lynch, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 11, 2021
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
Henry R Kranzler, Paige E Morris, Timothy Pond, et al.
Addictive Behaviors
|
January 31, 2002
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence
Kyle M Kampman, Joseph R Volpicelli, Frank Mulvaney, et al.
Journal of Substance Abuse Treatment
|
August 1, 2007
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence
Helen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Drug and Alcohol Dependence
|
May 16, 2006
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms
Kyle M Kampman, Charles Dackis, Kevin G Lynch, et al.
The American Journal on Addictions
|
September 25, 2014
A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence
Helen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Journal of Clinical Psychopharmacology
|
November 18, 2006
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking
Helen M Pettinati, Charles P O'Brien, Amanda R Rabinowitz, et al.
Addiction Biology
|
February 26, 2021
Sustained brain response to repeated drug cues is associated with poor drug-use outcomes
Paul S Regier, Kanchana Jagannathan, Teresa R Franklin, et al.
The American Journal of Psychiatry
|
March 17, 2010
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence
Helen M Pettinati, David W Oslin, Kyle M Kampman, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Journal of Addictive Diseases
|
September 26, 2002
Concurrent cocaine withdrawal alters alcohol withdrawal symptoms
Kyle M Kampman, Helen Pettinati, Joseph Volpicelli, et al.
Journal of Substance Abuse Treatment
|
March 2, 2012
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Charles A Dackis, Kyle M Kampman, Kevin G Lynch, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 11, 2021
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
Henry R Kranzler, Paige E Morris, Timothy Pond, et al.
Addictive Behaviors
|
January 31, 2002
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence
Kyle M Kampman, Joseph R Volpicelli, Frank Mulvaney, et al.
Journal of Substance Abuse Treatment
|
August 1, 2007
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence
Helen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Drug and Alcohol Dependence
|
May 16, 2006
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms
Kyle M Kampman, Charles Dackis, Kevin G Lynch, et al.
The American Journal on Addictions
|
September 25, 2014
A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence
Helen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Journal of Clinical Psychopharmacology
|
November 18, 2006
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking
Helen M Pettinati, Charles P O'Brien, Amanda R Rabinowitz, et al.
Addiction Biology
|
February 26, 2021
Sustained brain response to repeated drug cues is associated with poor drug-use outcomes
Paul S Regier, Kanchana Jagannathan, Teresa R Franklin, et al.
The American Journal of Psychiatry
|
March 17, 2010
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence
Helen M Pettinati, David W Oslin, Kyle M Kampman, et al.
Page
of 9